Molecular Neurobiology

Special Issues

Following special issues within this section are currently open for submissions:

• Oligodendrocyte Lineage Cells (Deadline: 15 March 2021)
• Neuroprotective Effect of Glutathione (Deadline: 15 March 2021)
• Neuroregenerative and Neuroprotective Strategies Based on Smart Nanomaterials (Deadline: 15 March 2021)
• Understanding TDP-43-Mediated Mechanisms in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (Deadline: 20 March 2021)
• Molecular Research on Neurological Visual Diseases (Deadline: 25 March 2021)
• The Regulation of the Cytoskeleton in the Healthy and Diseased Central Nervous System (Deadline: 31 March 2021)
• Modeling Neurological Disorders in Experimental Animals: New Insights and Emerging Roles (Deadline: 31 March 2021)
• Towards an Understanding of Retinal Diseases and Novel Treatment (Deadline: 31 March 2021)
• Neurobiology of Parkinson’s Disease (Deadline: 31 March 2021)
• CNS Injuries (Deadline: 31 March 2021)
• Protein Aggregates Toxicity: New Insights into the Mechanisms (Deadline: 31 March 2021)
• Cell Signaling in Neurodegeneration 2.0 (Deadline: 31 March 2021)
• Brain Hypoxia: Mechanisms of Resilience and Tolerance (Deadline: 31 March 2021)
• Electrophysiology of Alzheimer's Disease (Deadline: 31 March 2021)
• Individual Variability in Animal Models of Psychopathologies (Deadline: 31 March 2021)
• The Genetic and Mechanistic Basis of Human Neurodevelopmental Disorders (Deadline: 31 March 2021)
• Molecular Mechanisms of Polyglutamine Diseases (Deadline: 31 March 2021)
• Stem Cells in Neurodegenerative Pathologies (Deadline: 31 March 2021)
• Peripheral Biomarkers in Neurodegenerative Diseases 2.0 (Deadline: 31 March 2021)
• The Next Generation of Biomarkers at the Overlap of Neurodegenerative and Neuropsychiatric Diseases (Deadline: 31 March 2021)
• Omics-Based Molecular Mechanisms of Cognition under Stress (Deadline: 31 March 2021)
• New Strategies of Neuroprotection and Repair in the Developing Brain (Deadline: 15 April 2021)
• Cerebellar Ataxia (Deadline: 15 April 2021)
• Ischemic Brain Neurodegeneration (Deadline: 30 April 2021)
• Sodium Voltage-Operated Neural Channel Modulators in Peripheral Nervous System Disorders (Deadline: 30 April 2021)
• Brain Diseases: on Signaling Pathways and Miswired Networks (Deadline: 30 April 2021)
• Neurobiological Response of Thalamus to Stress or Trauma (Deadline: 30 April 2021)
• Molecular Mechanisms of Neuropathic Pain and Nerve Injury (Deadline: 30 April 2021)
• Pathogenesis and Treatment of Autism Spectrum Disorders (Deadline: 30 April 2021)
• Gender Related Molecular Mechanisms in Neurological Disorders (Deadline: 30 April 2021)
• Physiological or Pathological Molecular Alterations in Brain Aging (Deadline: 30 April 2021)
• New Molecular Insights into Neurocutaneous Syndromes (Deadline: 30 April 2021)
• Brain Mechanisms of Sleep Related Disorders (Deadline: 30 April 2021)
• GABAergic and Glycinergic Neurons (Deadline: 30 April 2021)
• Hypothalamic Regulation of Obesity (Deadline: 30 April 2021)
• Control of Astrocytes Function and Phenotype: Role in Neuropathology (Deadline: 30 April 2021)
• Neurogenetics in Neurology (Deadline: 30 April 2021)
• Glial Ion Channels and Transporters in Health and Disease (Deadline: 30 April 2021)
• Biomarkers for Meningioma (Deadline: 30 April 2021)
• Synaptic Transmission and Protein Interaction (Deadline: 30 April 2021)
• Epigenetic Regulation in Human Brain (Deadline: 30 April 2021)
• Molecular Mechanisms of Neural Stem Cells (NSC) Development - Systems Approach (Deadline: 30 April 2021)
• Neuronal Control of Locomotion (Deadline: 30 April 2021)
• Protein Kinases and Their Inhibitors in CNS Diseases (Deadline: 30 April 2021)
• Retinal Ganglion Cells 2.0 (Deadline: 15 May 2021)
• The Molecular Basis of Therapeutic Resistance of Brain Tumor (Deadline: 15 May 2021)
• Molecular Research on Rett Syndrome and Related Disorders (Deadline: 28 May 2021)
• Cellular and Molecular Mechanisms in Neurodevelopmental Disorders and Brain Tumors (Deadline: 31 May 2021)
• Advances in Knowledge in Niemann-Pick Disease Type C: Facts and Perspectives- 2nd Edition (Deadline: 31 May 2021)
• Glial Cells and Energy Intake: A Field That Is Gaining Weight (Deadline: 31 May 2021)
• Neurobiological Mechanisms Implicated in Stress-Related Psychiatric Disorders (Deadline: 31 May 2021)
• Trace Amine-Associated Receptors in Neuropsychiatric Disorders (Deadline: 31 May 2021)
• Molecular Mechanisms Underlying CNS Inflammation (Deadline: 31 May 2021)
• Molecular Insights in Psychiatry (Deadline: 31 May 2021)
• Molecular Mechanisms of Alzheimer’s Disease and Brain Tolerance (Deadline: 31 May 2021)
• Neurobiological Mechanisms of Orofacial Chronic Pain (Deadline: 31 May 2021)
• Effects of Hormones on the Nervous System and Behavior (Deadline: 31 May 2021)
• Epigenetic Regulation in Neurodegeneration Disease (Deadline: 31 May 2021)
• Neural Crest Development in Health and Disease (Deadline: 31 May 2021)
• The Mechanisms Regulation of the Neuromuscular Dysfunctions (Deadline: 31 May 2021)
• Neuroinflammation: From Molecular Mechanisms to Therapeutic Perspectives (Deadline: 31 May 2021)
• Molecular Mechanism Underlying Rare Inherited Neurological Diseases (Deadline: 31 May 2021)
• Cellular and Molecular Mechanisms of Traumatic Brain Injury and Concussion (Deadline: 20 June 2021)
• Molecular Mechanisms of Aging-Related Neurodegenerative Diseases (Deadline: 30 June 2021)
• Skeletal Muscle Denervation (Deadline: 30 June 2021)
• Molecular Mechanisms of Cerebrovascular Diseases (Deadline: 30 June 2021)
• Molecular Mechanisms and Treatments of Dependence and Neurotoxicity of Amphetamine-Type Stimulants (Deadline: 30 June 2021)
• Redox Active Metals in Neurodegenerative Diseases: Therapeutic Implications (Deadline: 30 June 2021)
• Common Chronic Diseases: Gap for the Treatment (Deadline: 30 June 2021)
• Neural Signaling, Neuromodulation and Plasticity (Deadline: 30 June 2021)
• Glycome and Nervous System (Deadline: 30 June 2021)
• Molecular Mechanisms of Synaptic Plasticity (3.0): Genetic and Environmental Factors Involved in Neuronal Changes (Deadline: 30 June 2021)
• Chronic Pain: Spinal and Sovraspinal Neuroinflammation and Associated Negative Affective States-2nd Edition (Deadline: 30 June 2021)
• Genomics of Brain Disorders 3.0 (Deadline: 30 June 2021)
• Epilepsy and Comorbidities in Children: Pathogenesis, Diagnosis and Therapies (Deadline: 30 June 2021)
• Precision Medicine and Therapy for Neurodegenerative Disorders (Deadline: 30 June 2021)
• Dementia and Cell Theraputic Strategies (Deadline: 30 June 2021)
• Molecular Mechanisms of Brain Repair and Restoration after Stroke (Deadline: 1 July 2021)
• Gene Therapy for Neurodegenerative Disease (Deadline: 15 July 2021)
• Molecular Mechanisms and Neural Correlates of General Anesthesia-2nd Edition (Deadline: 30 July 2021)
• Direct Genetic Conversion of Glia Cells to Neurons (Deadline: 31 July 2021)
• Brain/Mind Activity and Molecular Dynamics in Biological Systems (Deadline: 31 July 2021)
• Synaptic Plasticity and Diseases (Deadline: 31 July 2021)
• Understanding the Impacts of Neurodevelopmental Cannabinoid Exposure (Deadline: 31 July 2021)
• Therapeutic Potential of Targeting the Oxytocinergic System (Deadline: 31 July 2021)
• Molecular Pathogenesis of Neurodegeneration: From Fish to Human (Deadline: 31 July 2021)
• Non-genetic Modifiers of Synaptic Plasticity and Neurotransmission in the Central Nervous System (CNS) in Health and Disease (Deadline: 31 July 2021)
• Choroid Plexus: Novel Functions for An Old Structure 2.0 (Deadline: 31 July 2021)
• Molecular and Cellular Mechanisms of Synchronization within the Mammalian Circadian System (Deadline: 31 July 2021)
• Role of Tau Protein in Synaptic Deteriorarion of Alzheimer's Disease (AD) (Deadline: 31 July 2021)
• Alzheimer’s Disease and Other Dementias-Novel Therapeutic Approaches-2nd Edition (Deadline: 31 July 2021)
• Autoimmunity in the Nervous Systems: Multiple Sclerosis and Beyond (Deadline: 31 July 2021)
• Modulation of Neuronal Excitability, Synaptic Transmission, and Plasticity in Health and Disease 2.0 (Deadline: 31 July 2021)
• Neuropeptides, Receptors, and Behavior (Deadline: 31 July 2021)
• Steering Functional Pathways, Genomic and Non-genomic, to Keep Neurodegeneration in Check (Deadline: 31 July 2021)
• Nutritional and Inflammatory Biomarkers in Major Psychiatric Disorders (Deadline: 31 July 2021)
• The Role of Neuroimmune Inflammation in Chemotherapy-Induced Side Effects (Deadline: 31 July 2021)
• New Mechanisms and Therapeutics in Neurological Diseases (Deadline: 31 July 2021)
• Pathomechanism of Neurological and Neuropsychiatric Disorders, Neurodegeneration and Neuroprotection (Deadline: 31 August 2021)
• Ribbon Synapses: Molecular Mechanisms of Synaptic Signaling and Involvement in Diseases (Deadline: 31 August 2021)
• Neuronal, Glial, and Immune Changes in Models of Epilepsy and Epileptogenesis-2nd Edition (Deadline: 31 August 2021)
• Mast Cells in Human Health and Diseases (Deadline: 31 August 2021)
• Molecular Mechanisms on Huntington's Disease (Deadline: 31 August 2021)
• Neurobiology of Aging and Aging-Related Disorders (Deadline: 31 August 2021)
• The Molecular Brain and Its Health (Deadline: 31 August 2021)
• The Pathogenesis and Therapeutic Strategies for Understanding and Treating Diabetic Neuropathy of the Retina (Deadline: 31 August 2021)
• Effects of Environmental Factors on the Nervous Tissue Functioning: Molecular Bases of Neuropathogenic Mechanisms (Deadline: 31 August 2021)
• Molecular Mechanisms Underlying Neuropsychiatric Disorders and Their Treatment (Deadline: 31 August 2021)
• Non-Coding RNAs in Human Neurodevelopmental Disorders and Brain Disorders (Deadline: 31 August 2021)
• Disorders of Cholesterol Homeostasis (Deadline: 31 August 2021)
• Novel In Vitro and In Silico Approaches to Study Developmental Neurotoxicity (Deadline: 31 August 2021)
• Molecular Treatment in Optic Neuropathies (Deadline: 31 August 2021)
• Astrocytes: Emerging Roles in the Pathogenesis and Treatment of CNS Disorders 2.0 (Deadline: 31 August 2021)
• Molecular and Cellular Signaling on Antidepressant Mechanisms (Deadline: 31 August 2021)
• Proteinopathies in Frontotemporal Lobar Degeneration (Deadline: 31 August 2021)
• Drosophila Models for Neurodegenerative Diseases: Achievements and Prospects (Deadline: 31 August 2021)
• Role of the Vasculature in Neurological Disease (Deadline: 1 September 2021)
• Parkinson's Disease and Related Disorders: Mechanisms, Biomarkers, and Models (Deadline: 15 September 2021)
• Molecular Mechanisms, Pathophysiology and Phenotypes of Mitochondrial Disorders (Deadline: 30 September 2021)
• Prions and Prion Diseases 2.0 (Deadline: 30 September 2021)
• Newly Developed Drugs for Alzheimer's Disease (Deadline: 30 September 2021)
• Immunology of Neuropsychiatric Disorders (Deadline: 30 September 2021)
• Glial-Neuronal Interactions in Neurological Disorders: Molecular Mechanisms and Potential Points for Intervention 2.0 (Deadline: 30 September 2021)
• CNS Drug Action in Neurodegenerative Diseases 2.0 (Deadline: 30 September 2021)
• Neuroinflammation in Parkinson's Disease (Deadline: 30 September 2021)
• The Various Molecular Mechanisms Underlying Autism Spectrum Disorders (Deadline: 31 October 2021)
• Gangliosides: Modes of Action and Cell Fates II (Deadline: 31 October 2021)
• Neurolipids in Neurodegenerative Disorders (Deadline: 30 November 2021)
• Studying Functional and Molecular Connectome of the Human and Animal Brain (Deadline: 31 December 2021)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Feature Papers in Molecular Neurobiology
• Neuroinflammatory Processes in Neurodegenerative Diseases